Abu Dhabi-based PureHealth has announced a proposal for its first-ever dividend distribution since its listing on the Abu Dhabi Securities Exchange (ADX) in December 2023. The board of directors has recommended a total dividend of AED343 million ($93.39 million), which is equivalent to AED3.09 fils per share for the 2024 financial year. This proposal represents 20 percent of the group’s net profit.
Shareholder Approval Pending at AGM
The dividend proposal is set to be presented for approval at PureHealth’s annual general meeting (AGM) on April 9, 2025. Following the announcement, the company’s shares saw a notable increase of 4.5 percent, trading at AED3.01.
Strong Financial Performance in 2024
This dividend proposal follows the completion of PureHealth’s first full financial year as a publicly listed company. It highlights the strength of the group’s balance sheet, its ability to generate returns for shareholders, and its capacity to grow the business while maintaining a robust capital position.
PureHealth ended the 2024 financial year with exceptional results. The company reported revenues of AED25.8 billion, EBITDA of AED4.1 billion, and a net profit of AED1.7 billion. The group also maintained a substantial cash position of AED11.9 billion, coupled with a low leverage ratio of approximately 0.1x, providing it with ample strategic flexibility for future growth.
Focus on Global Expansion and Growth
PureHealth’s solid financial footing positions it well to pursue its ambitious growth and acquisition agenda. The group remains focused on expanding its presence and capabilities globally to drive excellence in its operations.
In line with its global expansion strategy, PureHealth recently acquired a 60 percent stake in Hellenic Healthcare Group from the global private equity firm CVC. CVC will remain a minority partner alongside PureHealth within the acquired entity, further strengthening its position in the international healthcare market.
